FIELD: biotechnology.
SUBSTANCE: following is presented: a complex of angiopoietin-like peptides (ANGPTL)3/8 to obtain antibodies that bind to the complex (ANGPTL)3/8, a nucleic acid encoding a polypeptide with the sequence of SEQ ID NO:19, an expression cassette and an expression vector containing nucleic acid, as well as the host cell to obtain the complex.
EFFECT: invention makes it possible to obtain a complex of angiopoietin-like peptides (ANGPTL)3/8, for obtaining antibodies that bind to the (ANGPTL)3/8 complex.
6 cl, 1 dwg, 14 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES AGAINST ANGPTL3/8 COMPLEX AND THEIR APPLICATION METHODS | 2019 |
|
RU2791034C2 |
| METHODS AND COMPOSITION FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES | 2010 |
|
RU2585488C2 |
| ANTIBODIES AGAINST IL-7R ALPHA SUBUNIT AND THEIR USE | 2020 |
|
RU2811912C2 |
| FUSED IMMUNOMODULATORY PROTEINS AND METHODS FOR PRODUCTION THEREOF | 2014 |
|
RU2698975C2 |
| EXPRESSION AND SECRETION SYSTEM | 2013 |
|
RU2670491C2 |
| FUSION IMMUNOMODULATORY PROTEINS AND METHODS FOR MAKING SAME | 2014 |
|
RU2662991C2 |
| OPTIMIZED OPTIONS OF ANTI-VEGF ANTIBODIES | 2016 |
|
RU2763916C2 |
| ANIMALS OTHER THAN A HUMAN HAVING A STRUCTURED ANGPTL8 GENE | 2017 |
|
RU2742354C2 |
| ANTIBODIES TO PD-1 AND COMPOSITIONS | 2016 |
|
RU2750675C1 |
| PD-1 ANTIBODIES | 2016 |
|
RU2686612C1 |
